Learn / GRAL
NASDAQ: GRALGRAIL (GRAL) stock, explained like you're 5
GRAIL trades on the Nasdaq under the ticker GRAL. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
- Ticker
- GRAL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Specialities
- Size
- Mid cap, about 6.3 billion dollars
Is GRAIL a small, medium or large cap company?
No. GRAIL is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How GRAIL makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves GRAL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone (Stocktwits)
- GRAIL (GRAL) Stock Sees Fair Value Lift After Analysts Back Galleri Outlook (Yahoo Finance)
- $GRAL stock is down 12% today. Here's what we see in our data. (Quiver Quantitative)
- GRAIL Reports Second Quarter 2026 Financial Results (GRAIL)
- GRAIL (GRAL) grants director 148 stock units in lieu of $20.2K in cash fees (Stock Titan)
Follow GRAL in your daily brief
Each trading day at 5 PM ET we post what happened to GRAIL and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow GRAL
Questions about GRAIL stock
What does GRAIL do?
GRAIL trades on the Nasdaq under the ticker GRAL. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 6.3 billion dollars.
What is the ticker symbol for GRAIL?
GRAIL trades under the ticker GRAL on the Nasdaq.
What is GRAIL's market cap?
GRAIL is a mid cap stock with a market cap of about 6.3 billion dollars.
How does GRAIL make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves GRAL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow GRAL stock every day?
Add GRAL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.
